URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


GPCRs - Targeted Drug Discovery Summit 2022


Date
Mar 22, 2022 - 08:00 AM - Mar 24, 05:00 PM
Organizer
Hanson Wade
Location
DoubleTree Suites by Hilton Hotel Boston - Cambridge, 400 Soldiers Field Road,

Boston,
MA,
US,
ZIP: 02134
Phone: + 1 415-735-3289

Ticket Price: USD 2599.00 - USD 4897.00

The inaugural GPCRs - Targeted Drug Discovery Summit has been established to tap into new drug discovery opportunities in undrugged and orphaned GPCRs by better understanding the complex signaling GPCR pathway, leveraging new structural and genetic data as well as, emerging screening tools and technologies and up and coming modalities.

Discover data driven case studies that showcase the challenges, learnings and takeaways currently being faced by large pharma, biotech and academia who are innovating their discovery and development approaches to drug a wider spectrum of clinically relevant but poorly characterized or undrugged GPCRs across a broad range of therapeutic areas such as oncology, age-related diseases and beyond.

Whether you are looking to harness the power of structural biology tools or emerging technologies, join fellow directors, heads and VPs of drug discovery, structural biology, and pharmacology at the GPCRs - Targeted Drug Discovery Summit - the most comprehensive and dedicated scientific and networking forum for innovative biopharma and research institutes to seize the therapeutic opportunities of GPCRs.

Tickets    https://go.evvnt.com/947654-1?pid=1052
Brochure https://go.evvnt.com/947654-2?pid=1052

Prices:
Conference Only - Drug Developer USD 2999.00
Conference + Focus Day - Drug Developer USD 4297.00
Conference + Focus Day - Standard Pricing USD 4897.00
Conference Only - Standard Pricing USD 3599.00
Conference + Focus Day - Academic & Research Institute USD 3697.00
Conference Only - Academic & Research Institute USD 2599.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals


Speaker Details


Christel Menet, CSO, Confo Therapeutics, Christian Cortis, COO, Tectonic Therapeutic, Graeme Milligan, Professor of Biochemistry, University of Glasgow, Michael Hanson, CTO, ShouTi, Francis Willard, Research Advisor, Eli Lilly, Peter McNamara, SVP & Head of Research, Tectonic Therapeutic, Stacey Southall, Director - Biophysics / Cryo-EM, Sosei Heptares, Uli Stilz, VP, Novo Nordisk Bio Innovation Hub, Josephine Cardarelli, CSO, GPCR Therapeutics, Monica Schwartz, Director, Abalone Bio, Stuart Hughes, CEO, Pathios Therapeutics, Xavier Leroy, CSO, Domain Therapeutics, Brett Tounge, Co-Founder, Mebias Discovery, Leon Chan, Head of Biology, Octant, Naomi Handly, Head of Platform, Octant, Stuart Maudsley, Odysseus Professor of Receptor Pharmacology & Vice Chair & Co-Founder, University of Antwerp & heptOME, Barbara Cipriani, Head of Biology, Pathios Therapeutics, John McCorvy, Assistant Professor, Medical College of Wisconsin, Juan José Fung, Principal Scientist, GPCR Therapeutics, Robin Löving, CSO, Salipro Biotech, Gregory Tall, Associate Professor, University of Michigan Medical School, Irina Tikhonova, Reader, Queen’s University Belfast, Oliver Hartley, VP - Drug Discovery, Orion Biotechnology, Scott Prosser, Professor of Biophysical Chemistry, University of Toronto

Event Categories
Keywords: conference




Comments








Events Calendar

SunMonTueWedThuFriSat
27 28 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99